We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Medicare Payment Advisory Commission (MedPAC), an independent congressional agency, is calling for an approval pathway for biosimilars as a way to increase competition and make better use of government health spending.